...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

I have almost become immune to hope in the current retail market haha ... until official word from the FDA regarding path forward, Nasdaq (legitimacy & market), or a significant BP partner/buyer.  

I DO believe this to be a winner "eventuallly" though at some point (4-36 months?). So, not looking to be negative, just pragmatic. Would love to be wrong, and see the pps ttake off prior to the above mentioned issues & opportunities.

Hoping for GREAT Cognitive data, to go with the other previously disclosed excellent data to keep things moving forward on all fronts, and hopefully a mild-moderate effect on the pps, while waiting for "other" news and milestones. 

All speculation and jmho's of course

Share
New Message
Please login to post a reply